Amelia Mathew
Psychiatry · Gainesville, GANPI 1376562488
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations.
Across 133 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$410
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$281
- Lundbeck LLC$273
- Supernus Pharmaceuticals, Inc.$263
- AbbVie$226
- Corium, LLC$209
- plus $1K from 10 others
What the payments were for
- Food & beverage$2,695100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 13 | $410 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $281 |
| Lundbeck LLC | 12 | $273 |
| Supernus Pharmaceuticals, Inc. | 14 | $263 |
| AbbVie | 17 | $226 |
| Corium, LLC | 12 | $209 |
| Otsuka America Pharmaceutical, Inc. | 9 | $207 |
| Tris Pharma Inc | 10 | $191 |
| Neurocrine Biosciences, Inc. | 8 | $189 |
| Noven Therapeutics, LLC | 5 | $98 |
| Axsome Therapeutics, Inc. | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| Alkermes, Inc. | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$142
How this compares
$2,695 in reported general payments places this provider in the 80th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 12 | $2,094 |
| Gabapentin | 29 | $757 |
| Bupropion XlBupropion Hcl | 15 | $423 |
| Olanzapine | 11 | $290 |
| Duloxetine Hcl | 23 | $261 |
| Citalopram HbrCitalopram Hydrobromide | 15 | $217 |
| Lamotrigine | 12 | $98 |
| Diazepam | 12 | $51 |
| Lorazepam | 12 | $10 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Gainesville
- Shahzad HashmiGainesville$70K
- Richard PettyLoganville$2.9M
- Ann GrooverCalhoun$1.4M
- Todd AntinDecatur$1M
- Michael BanovMarietta$733K
- Ben HunterBrookhaven$499K
- Joel MorganValdosta$337K
- Munjal ShroffSmyrna$316K
- David PurselleAtlanta$307K
- Jose CangianoAthens$244K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.